Recombinetics: Recombinetics Inc. to Partner with American Preclinical Services to Improve Glioblastoma Outcomes
Recombinetics Inc., a leading gene editing company with platform technology applied to biomedicine and animal agriculture, today announced that it has partnered with American Preclinical Services in a first of its kind study to improve Glioblastoma outcomes.
Read full article »
Recombinetics is a Minnesota-based biotech firm that offers animal gene editing and gene repairing services in sectors including biomedical research and regenerative medicine.
Read more